News

 MALAYSIA: Circular Letter Recognizing IMR Malaysia As A Credible Source To Provide Clinical Evaluation Data for Clinical Trials Conducted in Malaysia - November 2017

MALAYSIA: Circular Letter Recognizing IMR Malaysia As A Credible Source To Provide Clinical Evaluation Data for Clinical Trials Conducted in Malaysia - November 2017

  • 2020-02-15 06:20:38

A new Circular Letter was released by Medical Device Authority (MDA) on October 2, 2017, in which MDA recognizes Institute of Medical Research (IMR) Malaysia as a credible source to provide clinical evaluation data for conformity assessment purposes conducted by a Conformity Assessment Bodies (CAB) in Malaysia. This Circular Letter comes into effect starting October 2, 2017.

More